KR20100014974A - 아미드 화합물 및 이의 항종양제로서의 용도 - Google Patents

아미드 화합물 및 이의 항종양제로서의 용도 Download PDF

Info

Publication number
KR20100014974A
KR20100014974A KR1020097018936A KR20097018936A KR20100014974A KR 20100014974 A KR20100014974 A KR 20100014974A KR 1020097018936 A KR1020097018936 A KR 1020097018936A KR 20097018936 A KR20097018936 A KR 20097018936A KR 20100014974 A KR20100014974 A KR 20100014974A
Authority
KR
South Korea
Prior art keywords
nmr
mhz
mmol
cdcl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020097018936A
Other languages
English (en)
Korean (ko)
Inventor
스테판 하네시안
루치아나 아우자스
기우세페 지안니니
클라우디오 피사노
로레다나 베스치
왈테르 카브리
Original Assignee
시구마-토우인더스트리에파아마슈우티히리유니트에스.피이.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시구마-토우인더스트리에파아마슈우티히리유니트에스.피이.에이. filed Critical 시구마-토우인더스트리에파아마슈우티히리유니트에스.피이.에이.
Publication of KR20100014974A publication Critical patent/KR20100014974A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/01—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020097018936A 2007-03-13 2008-03-12 아미드 화합물 및 이의 항종양제로서의 용도 Withdrawn KR20100014974A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07104071 2007-03-13
EP07104071.1 2007-03-13

Publications (1)

Publication Number Publication Date
KR20100014974A true KR20100014974A (ko) 2010-02-11

Family

ID=39535770

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097018936A Withdrawn KR20100014974A (ko) 2007-03-13 2008-03-12 아미드 화합물 및 이의 항종양제로서의 용도

Country Status (13)

Country Link
US (1) US20100113504A1 (cg-RX-API-DMAC7.html)
EP (1) EP2137169A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010520915A (cg-RX-API-DMAC7.html)
KR (1) KR20100014974A (cg-RX-API-DMAC7.html)
CN (1) CN101641341A (cg-RX-API-DMAC7.html)
AU (1) AU2008225833A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0809000A2 (cg-RX-API-DMAC7.html)
CA (1) CA2677874A1 (cg-RX-API-DMAC7.html)
EA (1) EA200970848A1 (cg-RX-API-DMAC7.html)
IL (1) IL200188A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009009374A (cg-RX-API-DMAC7.html)
WO (1) WO2008110583A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200907077B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2230227A1 (en) * 2009-03-20 2010-09-22 Bracco Imaging S.p.A Process for the preparation of triiodinated carboxylic aromatic derivatives
JP2013508323A (ja) * 2009-10-21 2013-03-07 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 合成大環状アミドhdac6阻害剤化合物およびそれらの治療剤としての用途
CN109516926B (zh) * 2018-07-27 2021-09-17 四川大学 一种荜茇明碱衍生物制备及用途
EP3941457B1 (en) * 2019-03-21 2026-01-21 Merck Sharp & Dohme LLC Inhibitors of histone deacetylase useful for the treatment or prevention of hiv infection
CN120924186B (zh) * 2025-10-14 2025-12-23 长沙市芯星新能源科技有限公司 负极粘结剂、锂离子电池负极及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0014254A (pt) * 1999-09-08 2002-08-27 Sloan Kettering Inst Cancer Nova classe de agentes de citodiferenciação e inibidores de desacetilase de histona, e métodos de uso dos mesmos
AU2006228957A1 (en) * 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase

Also Published As

Publication number Publication date
US20100113504A1 (en) 2010-05-06
WO2008110583A1 (en) 2008-09-18
AU2008225833A1 (en) 2008-09-18
IL200188A0 (en) 2010-04-15
CA2677874A1 (en) 2008-09-18
ZA200907077B (en) 2010-07-28
JP2010520915A (ja) 2010-06-17
MX2009009374A (es) 2009-09-21
EP2137169A1 (en) 2009-12-30
BRPI0809000A2 (pt) 2014-11-11
EA200970848A1 (ru) 2010-02-26
CN101641341A (zh) 2010-02-03

Similar Documents

Publication Publication Date Title
CN114524821B (zh) 螺旋吡咯烷衍生的抗病毒药物
RU2638923C2 (ru) Синтез карбамоилпиридоновых ингибиторов интегразы ВИЧ и промежуточных соединений
US8816122B2 (en) Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use
CA2802216C (en) Tetrahydrocarboline derivative and its use as an enpp2 inhibitor
JP7264060B2 (ja) 二環式化合物および癌の処置におけるそれらの使用
JP2016519653A (ja) Ido阻害剤
KR20050087865A (ko) HIV 인테그라제 억제제로서 유용한테트라하이드로-4H-피리도[1,2-a]피리미딘 및 관련화합물
EA024681B1 (ru) Имидазопиридины в качестве противовирусных средств против респираторно-синцитиального вируса
EA020885B1 (ru) Ингибиторы протеинкиназы и их применение
KR20140059164A (ko) 트라이사이클릭 자이라제 억제제
CN109422737B (zh) 咪唑酮类雄激素受体拮抗剂、其制备方法和用途
DE69533043T2 (de) Acrylamid-derivate und verfahren zu deren herstellung
SK17022001A3 (sk) Deriváty a analógy galantamínu
ES2587952T3 (es) Compuestos químicos
JP2025156455A (ja) チアゾロ[5,4-b]ピリジンMALT-1阻害剤
JP2010520915A (ja) アミド化合物および抗腫瘍剤としてのその使用
EP4680336A1 (en) Amide derivatives for inhibiting nlrp3 and uses thereof
KR20020032618A (ko) 히드록삼산 유도체 화합물, 그 제조 방법 및 그 화합물을유효 성분으로 하는 의약
JP4779058B2 (ja) α−アミノ基−N−置換アミド化合物、該化合物を含む薬剤組成物及びその用途
TWI659022B (zh) 作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物
US12377070B2 (en) Substituted sulfoximine derivatives
CN118515653B (zh) 一种ezh2特异性抑制剂及其制备方法和用途
KR102717168B1 (ko) 표적 단백질의 분해를 유도하기 위한 데그라듀서, 이의 제조방법 및 이를 유효성분으로 함유하는 표적 단백질 관련 질환의 예방 또는 치료용 약학적 조성물
EA026676B1 (ru) Спироциклические циклопропановые аминокислоты и лекарственные средства на их основе
CN121735902A (zh) Lat1介导的sting激动剂前药及其制备方法和医药用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090910

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid